Biogen Buys China Rights to Immune Disease Drug in up to $850 Million Deal with TJ Biopharma

Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma Reuters

Biogen buys China rights to immune disease drug in up to $850 million deal with TJ Biopharma Reuters

Source: Reuters Business (via Google News)

Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *